We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microscopy and Molecular Assay Compared for Schistosomiasis Diagnosis

By LabMedica International staff writers
Posted on 12 Aug 2015
The current reference test for the detection of Schistosoma mansoni in endemic areas is stool microscopy based on one or more Kato-Katz stool smears, but this technique is highly observer-dependent and has suboptimal sensitivity.

Polymerase chain reaction (PCR), in a multiplex format, has the some advantages over microscopy, with greater flexibility as a multiplex PCR can detect all Schistosoma and other helminth species at the same time, and at any moment after the stool has been collected.

Scientists at Leiden University Medical Center (the Netherlands) led an international team to compare the performance of stool microscopy with the highly specific real-time polymerase chain reaction (RT-PCR) for the detection and quantification of parasite specific DNA. More...
Microscopy and PCR were performed in a Senegalese community of 197 in an area with high S. mansoni transmission and co-occurrence of S. haematobium, and in 760 Kenyan schoolchildren from an area with comparatively low S. mansoni transmission.

In Senegal, two stool and two urine samples were collected from each participant on consecutive days. From each stool sample, a duplicate 25 mg Kato-Katz slide was prepared for quantitative detection of Schistosoma spp. eggs and qualitative diagnosis of soil transmitted helminths (STHs) Ascaris lumbricoides and Trichuris trichiura by microscopy. A Schistosoma multiplex real-time PCR (Schisto-PCR) was performed on DNA isolated from feces samples. This PCR targets the Schistosoma-specific internal transcriber-spacer-2 (ITS2) sequence of S. mansoni, S. haematobium, and S. intercalatum. Amplification, detection and data analysis were performed with the CFX96 Real-Time System version 1.1 (Bio-Rad; Hercules, CA, USA).

Despite the differences in Schistosoma endemicity the PCR performed very similarly in both areas; 13%–15% more infections were detected by PCR when comparing to microscopy of a single stool sample. Even when two to three stool samples were used for microscopy, PCR on one stool sample detected more infections, especially in people with light-intensity infections and in children from low-risk schools. The low prevalence of soil-transmitted helminthiasis in both populations was confirmed by an additional multiplex PCR.

The authors concluded that the ITS2-based PCR was more sensitive than standard microscopy in detecting Schistosoma spp. This would be particularly useful for S. mansoni detection in low transmission areas, and post-control settings, and as such improve schistosomiasis control programs, epidemiological research, and quality control of microscopy. Moreover, it can be complemented with other multiplex real-time PCRs to detect a wider range of helminths and thus enhance effectiveness of current integrated control and elimination strategies for neglected tropical diseases. The study was published on July 28, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Leiden University Medical Center 
Bio-Rad



New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A simple blood sample that allows DNA methylation could identify epigenetic biomarkers (Photo courtesy of 123RF)

Simple Blood Sample Could Identify Epigenetic Biomarkers to Predict CVD Risk in Type 2 Diabetes

People with type 2 diabetes face up to four times higher risk of cardiovascular events such as heart attacks, strokes, and angina compared to individuals without the condition. Yet, current tools used... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more

Industry

view channel
Image: The acquisition of Exosome Diagnostics adds the ExoDx Prostate test to Mdxhealth’s portfolio (Photo courtesy of Bio-Techne)

Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has entered into an agreement with Mdxhealth SA (Irvine, CA, USA), which will acquire its Exosome Diagnostics Inc. (Waltham, MA, US) business, including the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.